<p><p><i>Sequential Experimentation in Clinical Trials: Design and Analysis</i> is developed from decades of work in research groups, statistical pedagogy, and workshop participation. Different parts of the book can be used for short courses on clinical trials, translational medical research, and se
Recent Advances in Clinical Trial Design and Analysis
โ Scribed by David L. DeMets, Gordon Lan (auth.), Peter F. Thall Ph.D. (eds.)
- Publisher
- Springer US
- Year
- 1995
- Tongue
- English
- Leaves
- 262
- Series
- Cancer Treatment and Research 75
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
Clinical trials have two purposes -- to treat the patients in the trial, and to obtain information which increases our understanding of the disease and especially how patients respond to treatment. Statistical design provides a means to achieve both these aims, while statistical data analysis provides methods for extracting useful information from the trial data.
Recent advances in statistical computing have enabled statisticians to implement very rapidly a broad array of methods which previously were either impractical or impossible. Biostatisticians are now able to provide much greater support to medical researchers working in both clinical and laboratory settings. As our collective toolkit of techniques for analyzing data has grown, it has become increasingly difficult for biostatisticians to keep up with all the developments in our own field. Recent Advances in Clinical Trial Design and Analysis brings together biostatisticians doing cutting-edge research and explains some of the more recent developments in biostatistics to clinicians and scientists who work in clinical trials.
โฆ Table of Contents
Front Matter....Pages i-x
The alpha spending function approach to interim data analyses....Pages 1-27
Issues in the design and analysis of AIDS clinical trials....Pages 29-47
Recent developments in the design of phase II clinical trials....Pages 49-71
Multivariate failure time data....Pages 73-93
Goodness-of-fit and diagnostics for proportional hazards regression models....Pages 95-112
A review of tree-based prognostic models....Pages 113-124
Decision analysis and Bayesian methods in clinical trials....Pages 125-154
A Bayesian model for evaluating specificity of treatment effects in clinical trials....Pages 155-175
The exact analysis of contingency tables in medical research....Pages 177-202
Stratified-adjusted versus unstratified assessment of sample size and power for analyses of proportions....Pages 203-223
Quality-of-life assessment in clinical trials....Pages 225-246
Back Matter....Pages 247-258
โฆ Subjects
Oncology; Cancer Research; Statistics for Life Sciences, Medicine, Health Sciences
๐ SIMILAR VOLUMES
Translating laboratory discoveries into successful therapeutics can be difficult. Clinical Trials in Neurology aims to improve the efficiency of clinical trials and the development of interventions in order to enhance the development of new treatments for neurologic diseases. It introduces the reade
''Translating laboratory discoveries into successful therapeutics can be difficult. Clinical Trials in Neurology aims to improve the efficiency of clinical trials and the development of interventions in order to enhance the development of new treatments for neurologic diseases. It introduces the rea
<P><STRONG>Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis</STRONG> provides statisticians with an understanding of the critical challenges currently encountered in oncology trials. Well-known statisticians from academic institutions, regulatory and government agencie
<p>Multiple Sclerosis: Advances in Clinical Trial Design, Treatment and Future Perspectives is a review of therapeutic developments for a disease that is one of the major problems in current neurologic practice. Progress in this field has been rapid and there have been important developments in clin